These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 2723094)

  • 1. Assessment of cognitive functioning in poly-substance abusers.
    Sweeney JA; Meisel L; Walsh VL; Castrovinci D
    J Clin Psychol; 1989 Mar; 45(2):346-51. PubMed ID: 2723094
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cognitive functioning in substance abuse and dependence: a population-based study of young adults.
    Latvala A; Castaneda AE; Perälä J; Saarni SI; Aalto-Setälä T; Lönnqvist J; Kaprio J; Suvisaari J; Tuulio-Henriksson A
    Addiction; 2009 Sep; 104(9):1558-68. PubMed ID: 19686526
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuropsychological impairment in chronic cocaine abusers.
    O'Malley S; Adamse M; Heaton RK; Gawin FH
    Am J Drug Alcohol Abuse; 1992; 18(2):131-44. PubMed ID: 1562011
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cognitive impairments in poly-drug ketamine users.
    Liang HJ; Lau CG; Tang A; Chan F; Ungvari GS; Tang WK
    Addict Behav; 2013 Nov; 38(11):2661-6. PubMed ID: 23899429
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Incidental Learning: A Brief, Valid Measure of Memory Based on the WAIS-IV Vocabulary and Similarities Subtests.
    Spencer RJ; Reckow J; Drag LL; Bieliauskas LA
    Cogn Behav Neurol; 2016 Dec; 29(4):206-211. PubMed ID: 27984258
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chronic solvent abuse. 1. Cognitive sequelae.
    Zur J; Yule W
    Child Care Health Dev; 1990; 16(1):1-20. PubMed ID: 2311197
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Estimation of K-WAIS-IV Premorbid Intelligence in South Korea: Development of the KPIE-IV.
    Kim SG; Lee EH; Hwang ST; Park K; Chey J; Hong SH; Kim JH
    Clin Neuropsychol; 2015; 29 Suppl 1():19-29. PubMed ID: 26247852
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comorbid substance abuse and neurocognitive function in recent-onset schizophrenia.
    Wobrock T; Sittinger H; Behrendt B; D'Amelio R; Falkai P; Caspari D
    Eur Arch Psychiatry Clin Neurosci; 2007 Jun; 257(4):203-10. PubMed ID: 17131214
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Measurement of recovery after traumatic brain injury: a cognitive-neuropsychological comparison of the WAIS-R with the cognitive assessment system (CAS) in a single case of atypical language lateralization.
    McCrea SM
    Appl Neuropsychol; 2007; 14(4):296-304. PubMed ID: 18067427
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Construct validity of the Babcock Story Recall Test.
    Horner MD; Teichner G; Kortte KB; Harvey RT
    Appl Neuropsychol; 2002; 9(2):114-6. PubMed ID: 12214822
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ecstasy use: cognitive deficits related to dosage rather than self-reported problematic use of the drug.
    Fox HC; Parrott AC; Turner JJ
    J Psychopharmacol; 2001 Dec; 15(4):273-81. PubMed ID: 11769821
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of chronic alcoholism on hemispheric functioning: an examination of gender differences for cognitive and dichotic listening tasks.
    Drake AI; Hannay HJ; Gam J
    J Clin Exp Neuropsychol; 1990 Oct; 12(5):781-97. PubMed ID: 2258437
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neurocognitive impairment: the unrecognized component of dual diagnosis in substance abuse treatment.
    Meek PS; Clark HW; Solana VL
    J Psychoactive Drugs; 1989; 21(2):153-60. PubMed ID: 2760756
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Verbal learning and memory in alcohol abusers and polysubstance abusers with concurrent alcohol abuse.
    Bondi MW; Drake AI; Grant I
    J Int Neuropsychol Soc; 1998 Jul; 4(4):319-28. PubMed ID: 9656605
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuropsychologic impairment and MRI abnormalities associated with chronic solvent abuse.
    Rosenberg NL; Grigsby J; Dreisbach J; Busenbark D; Grigsby P
    J Toxicol Clin Toxicol; 2002; 40(1):21-34. PubMed ID: 11990201
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The relationship between length of stay in drug-free therapeutic communities and neurocognitive functioning.
    Fals-Stewart W; Schafer J
    J Clin Psychol; 1992 Jul; 48(4):539-43. PubMed ID: 1325478
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effect of comorbid substance use on neuropsychological performance in subjects with psychotic or mood disorders].
    Liraud F; Verdoux H
    Encephale; 2002; 28(2):160-8. PubMed ID: 11972143
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Education and cognitive function in Alzheimer's disease.
    Filley CM; Cullum CM
    Neuropsychiatry Neuropsychol Behav Neurol; 1997 Jan; 10(1):48-51. PubMed ID: 9118196
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vocabulary deficit and abstraction impairment in hospitalized alcoholics.
    Draper RJ; Manning A
    Psychol Med; 1982 May; 12(2):341-7. PubMed ID: 7100357
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of substance abuse on visuographic function.
    Amir T; Bahri T
    Percept Mot Skills; 1994 Feb; 78(1):235-41. PubMed ID: 8177664
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.